Andreas Pfestroff

1.9k total citations
36 papers, 748 citations indexed

About

Andreas Pfestroff is a scholar working on Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andreas Pfestroff has authored 36 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 15 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andreas Pfestroff's work include Thyroid Cancer Diagnosis and Treatment (14 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Neuroendocrine Tumor Research Advances (6 papers). Andreas Pfestroff is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (14 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Neuroendocrine Tumor Research Advances (6 papers). Andreas Pfestroff collaborates with scholars based in Germany, United States and Netherlands. Andreas Pfestroff's co-authors include Damiano Librizzi, Olivia M. Merkel, Thomas Kissel, Tino Schurrat, Martin Béhé, Thomas M. Behr, Markus Luster, Peter Barth, Brian S. Sproat and Andrea Beyerle and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Andreas Pfestroff

33 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Pfestroff Germany 12 380 181 167 115 91 36 748
R. Mairs United Kingdom 19 219 0.6× 189 1.0× 173 1.0× 138 1.2× 96 1.1× 47 852
Hyo Jung Seo South Korea 11 167 0.4× 205 1.1× 123 0.7× 82 0.7× 45 0.5× 25 565
Jocelyn F. Burke United States 11 422 1.1× 180 1.0× 39 0.2× 60 0.5× 50 0.5× 18 619
Sabine Zitzmann Germany 13 383 1.0× 284 1.6× 34 0.2× 136 1.2× 63 0.7× 17 679
Melissa Nelson United States 11 185 0.5× 208 1.1× 53 0.3× 197 1.7× 35 0.4× 21 516
Mary‐Keara Boss United States 11 142 0.4× 98 0.5× 205 1.2× 161 1.4× 45 0.5× 41 616
Mengjuan Mu China 10 193 0.5× 81 0.4× 248 1.5× 58 0.5× 29 0.3× 18 440
Christian Huidobro Chile 17 273 0.7× 48 0.3× 254 1.5× 192 1.7× 55 0.6× 31 699
Gaurav Malviya Italy 16 162 0.4× 184 1.0× 75 0.4× 173 1.5× 32 0.4× 34 620
Le-Cun Xu United States 8 226 0.6× 172 1.0× 63 0.4× 246 2.1× 42 0.5× 12 608

Countries citing papers authored by Andreas Pfestroff

Since Specialization
Citations

This map shows the geographic impact of Andreas Pfestroff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Pfestroff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Pfestroff more than expected).

Fields of papers citing papers by Andreas Pfestroff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Pfestroff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Pfestroff. The network helps show where Andreas Pfestroff may publish in the future.

Co-authorship network of co-authors of Andreas Pfestroff

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Pfestroff. A scholar is included among the top collaborators of Andreas Pfestroff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Pfestroff. Andreas Pfestroff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wächter, Sabine, Detlef K. Bartsch, Jorge Riera Knorrenschild, et al.. (2025). Mutation-based, neoadjuvant treatment for advanced anaplastic thyroid carcinoma. Frontiers in Endocrinology. 16. 1619875–1619875.
2.
Scherthan, Harry, Andreas Pfestroff, Philipp E. Hartrampf, et al.. (2021). DNA damage and repair in peripheral blood mononuclear cells after internal ex vivo irradiation of patient blood with 131I. European Journal of Nuclear Medicine and Molecular Imaging. 49(5). 1447–1455. 14 indexed citations
3.
Kreißl, Michael C., et al.. (2021). Therapiekonzepte beim Schilddrüsenkarzinom. Nuklearmedizin - NuclearMedicine. 61(3). 223–230. 1 indexed citations
4.
Pfestroff, Andreas, et al.. (2021). Theranostics in Thyroid Cancer. PET Clinics. 16(3). 375–382. 3 indexed citations
5.
Pfestroff, Andreas, Markus Luster, Constantin Lapa, et al.. (2021). Real-World Efficacy and Safety of Multi-Tyrosine Kinase Inhibitors in Radioiodine Refractory Thyroid Cancer. Thyroid. 31(10). 1531–1541. 20 indexed citations
7.
Librizzi, Damiano, et al.. (2020). Score-based improvement of the indication for surgical treatment of thyroid lesions. Nuklearmedizin - NuclearMedicine. 59(3). 256–259.
8.
Loehrer, Philipp Alexander, et al.. (2020). Rhombencephalitis associated with isolated Zic4-antibodies in Paraneoplastic cerebellar degeneration: a case report. BMC Neurology. 20(1). 208–208. 10 indexed citations
9.
Verburg, Frederik A. & Andreas Pfestroff. (2016). PSMA PET–CT in initial prostate cancer staging. Nature Reviews Urology. 13(9). 498–499. 12 indexed citations
11.
Luster, Markus, Andreas Pfestroff, Heribert Hänscheid, & Frederik A. Verburg. (2016). Radioiodine Therapy. Seminars in Nuclear Medicine. 47(2). 126–134. 30 indexed citations
12.
Krug, Sebastian, Peter Rexin, Andreas Pfestroff, et al.. (2016). Acromegaly in a patient with a pulmonary neuroendocrine tumor: case report and review of current literature. BMC Research Notes. 9(1). 326–326. 8 indexed citations
13.
Luster, Markus, Andreas Pfestroff, & Frederik A. Verburg. (2016). Recent advances in nuclear medicine in endocrine oncology. Current Opinion in Oncology. 29(1). 1–6. 5 indexed citations
14.
Scharf, Michael E., Daniela Mueller, Andreas Pfestroff, et al.. (2014). Management of a metastasized high grade insulinoma (G3) with refractory hypoglycemia: Case report and review of the literature. Pancreatology. 14(6). 542–545. 11 indexed citations
15.
16.
Krug, Sebastian, Irene Portig, Damiano Librizzi, et al.. (2013). B-Symptomatik und Kauclaudicatio bei einem 79-jährigen Patienten. Der Internist. 54(2). 249–253. 1 indexed citations
17.
Krug, Sebastian, Detlef K. Bartsch, Martin Schöber, et al.. (2012). Successful selective internal radiotherapy (SIRT) in a patient with a malignant solid pseudopapillary pancreatic neoplasm (SPN). Pancreatology. 12(5). 423–427. 12 indexed citations
19.
Gratz, S., et al.. (2008). Unexpected 99mTc-tetrofosmin findings during myocardial perfusion scintigraphy: intraindividual comparison with PET/computed tomography. Nuclear Medicine Communications. 29(11). 963–969. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026